Company intelligence / Profile preview

IdentifySensors Biologics

Shaker Heights, Ohio, United States

Ownership: Private
Employees: ~108
Development stage: Other

Overview

The company is developing a rapid, lab-free digital diagnostic platform using graphene-based biosensors. Preliminary studies show promising results in detecting infections and cancers from saliva or blood samples.

Therapeutic areas: OncologyInfectious Diseases
Modalities: BiosensorsGraphene-based digital diagnostics
Industry: Molecular Diagnostics

Partnerships

Partnership with The Federation (for digital diagnostic technologies)East West Manufacturing (for device production)

Beyond the preview

Go deeper on IdentifySensors Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IdentifySensors Biologics.

Explore the full profile